Atea Pharmaceuticals (AVIR) Preferred Stock Liabilities (2020)
Atea Pharmaceuticals has reported Preferred Stock Liabilities over the past 1 years, most recently at $175.7 million for Q3 2020.
Atea Pharmaceuticals has reported Preferred Stock Liabilities over the past 1 years, most recently at $175.7 million for Q3 2020.